The myelodysplastic syndromes are a perfect example for the need for personalised treatment: they are extremely heterogeneous and no single type of treatment is effective in all patients
“It was an excellent idea to build up a special center dedicated to leukaemia and related disorders here in Barcelona. This center is collaborating with international research partners. The exchange to knowledge, techniques and ideas and the development of study protocols and projects with cooperating partners has tremendous impact on scientific progress”.